amoxicillin has been researched along with 2019 Novel Coronavirus Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 12 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barni, S; Capone, M; Caubet, JC; Giovannini, M; Liccioli, G; Mori, F; Parronchi, P; Sarti, L; Tomei, L | 1 |
| Ito, N; Kitahara, Y; Miwata, K; Nakamura, R; Okimoto, M; Takafuta, T | 1 |
| Benarous, K; Goumri-Said, S; Linani, A; Serseg, T | 1 |
| Del Fiol, FS; Pereira Andrade, I | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Kandilarov, N; Markovska, R; Yordanov, D | 1 |
| Ellakany, WI; Ghazy, RM; Ismail, A; Kamal, A; Sherief, D | 1 |
| Gitsham, A; Jarman, I; Malabar, L; McCabe, PG; McCloskey, AP | 1 |
| Abdullah, JAA; Alharthi, F; Eddine, LS; Hasan, GG; Legmairi, S; Meneceur, S; Mohammed, HA | 1 |
| Al Haroni, M; Lie, SA; Lund, B; Tousi, F | 1 |
| Bouma, M; de Jong, N; Loogman, MCM; Opstelten, W; Platteel, TN; Verheij, TJM | 1 |
| Desprez, D; Feugeas, O; Grunebaum, L; Hager, C; Sattler, L | 1 |
| Abraham, JA; Dickinson, L; Hurn, E | 1 |
1 trial(s) available for amoxicillin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; COVID-19; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Pandemics; Proton Pump Inhibitors; Treatment Outcome | 2023 |
11 other study(ies) available for amoxicillin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Simplifying the drug provocation test in non-immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; COVID-19; Drug Hypersensitivity; Humans; Pandemics; Retrospective Studies; Skin Tests; Tertiary Healthcare | 2022 |
Concurrent coronavirus disease 2019 and primary syphilis in a young man: A rare case report.
Topics: Adult; Amoxicillin; Antibodies, Bacterial; COVID-19; Humans; Male; Pandemics; Syphilis; Treponema pallidum; Ulcer | 2022 |
Repurposing antibiotics as potent multi-drug candidates for SARS-CoV-2 delta and omicron variants: molecular docking and dynamics.
Topics: Amoxicillin; Anti-Bacterial Agents; COVID-19; Drug Repositioning; Humans; Molecular Docking Simulation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines | 2023 |
Impact of COVID-19 on antibiotic prescriptions for Brazilian children.
Topics: Amoxicillin; Anti-Bacterial Agents; Brazil; Child; Child, Preschool; COVID-19; Drug Prescriptions; Humans; Infant; Practice Patterns, Physicians' | 2022 |
Geographic distribution of antibiotic resistance of Helicobacter pylori: A study in Bulgaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; COVID-19; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Pandemics | 2023 |
Antibiotic prescribing trends in primary care 2014-2022.
Topics: Amoxicillin; Anti-Bacterial Agents; COVID-19; Doxycycline; Erythromycin; Humans; Inappropriate Prescribing; Penicillin V; Practice Patterns, Physicians'; Primary Health Care; State Medicine; Trimethoprim | 2023 |
Enhanced photocatalytic activity and antiviral evaluation of CuO@Fe
Topics: Amoxicillin; Antiviral Agents; Copper; COVID-19; Humans; SARS-CoV-2; Spectroscopy, Fourier Transform Infrared | 2023 |
Antibiotic prescriptions among dentists across Norway and the impact of COVID-19 pandemic.
Topics: Amoxicillin; Anti-Bacterial Agents; COVID-19; Dentists; Humans; Norway; Pandemics; Prescriptions | 2023 |
[Respiratory complaints in the time of COVID-19].
Topics: Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Coronavirus Infections; COVID-19; Female; General Practice; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiratory Tract Infections; SARS-CoV-2; Triage | 2020 |
COVID-19 in a pediatric patient with Glanzmann thrombasthenia.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Computed Tomography Angiography; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Feces; Female; Fibrin Fibrinogen Degradation Products; Hematologic Agents; Hospitalization; Humans; Menorrhagia; SARS-CoV-2; Thorax; Thrombasthenia; Treatment Outcome | 2020 |
Bacterial meningitis and COVID-19: a complex patient journey.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Coinfection; Combined Modality Therapy; Communication; Confusion; COVID-19; Critical Care; Diagnosis, Differential; Female; Fever; Headache; Humans; Meningitis, Escherichia coli; Patient Care Team; Physical Therapy Modalities; Physician-Patient Relations; Respiration, Artificial; SARS-CoV-2; Treatment Outcome | 2021 |